Kiora Pharmaceuticals Competitors and Similar CompaniesClear all
Kiora Pharmaceuticals's competitors and similar companies include GBT (Global Blood Therapeutics), Heron Therapeutics, Camurus and Sosei Heptares.
 Kiora Pharmaceuticals Kiora Pharmaceuticals (formerly known as Panoptes Pharma) is a clinical-stage biotech company focused on developing small molecule-based therapies for the treatment of severe eye diseases. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. |  Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. | ||
Founding Date | Founding Date 2013 | Founding Date 2012 | Founding Date 1983 | Founding Date 1991 | Founding Date 1990 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Wien, AT HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations San Diego, US HQ | Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB |
Employees | Employees 1025% increase | Employees 352106% increase | Employees 20333% decrease | Employees 265 | Employees 387 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 268.5 m | Valuation ($) 3.4 b | Valuation ($) 697 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $154.9m (FY, 2025) | Revenue (est.) kr2.3b (FY, 2025) | Revenue (est.) ¥29.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods $41.3m (FY, 2025) | Cost of goods kr138.7m (FY, 2025) | Cost of goods ¥7.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $113.6m (FY, 2025) | Gross profit kr2.1b (FY, 2025) | Gross profit ¥24b (FY, 2025) |
Net income | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income ($20.2m) (FY, 2025) | Net income kr735.6m (FY, 2025) | Net income (¥12.5b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 88.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View companyCamurus
HQ
Lund, SE
Employees
265
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
View company
Sosei Heptares
HQ
Tokyo, JP
Employees
387
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
View company